These findings indicate that the in vitro stimulation of TLR3-positive human lung cancer cells with synthetic TLR3 agonist induces apoptosis in tumor cells and that TLR3-mediated apoptosis of lung cancer cells increases the activation of the CD103+ subset of lung dendritic cells. The gene discussed is TLR3; the disease is neoplasm.